he U.S. Food and Drug Administration (FDA) has approved Novo Nordisk’s application to market a new formulation of the drugmaker’s type 2 diabetes drug Ozempic (semaglutide) as a once-weekly
New Way to Slow Kidney Disease Progression
A research team at the University of Bristol in England has reported the discovery of a new method of slowing the progression of kidney disease, an ailment that, according the U.S. Centers for Disease Control and Prevention (CDC), affects one in thre
